NIH-funded research Career grant

Understanding how T cells make IFN-γ and IL-17 in kids with juvenile arthritis

Official title: Mechanisms of T Cell IFNy and IL-17 Production in Juvenile Idiopathic Arthritis

Funded at Vanderbilt University Medical Center · NIH-11392245 · Data updated 2026-11-12

A doctor-scientist at Vanderbilt is studying why certain immune cells in children with juvenile idiopathic arthritis produce inflammatory signals, with the goal of improving diagnosis and treatment.

More Arthritis research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startAugust 24, 2022
Project endJuly 31, 2027
Funding year2026
Award (this year)$163,836
NIH project number5K08AR081405-05
Project IDNIH-11392245 on NIH RePORTER

Who could benefit from this research

Could help

Children with juvenile idiopathic arthritis who have or may have abnormalities in Th1/Th17 cell pathways.

Less likely to help

Children whose disease is not driven by Th1/Th17 pathways may see limited benefit.

What this research studies

This grant focuses on how specific T cells (Th1 and Th17) and their inflammatory signals (IFN-γ and IL-17) develop in juvenile idiopathic arthritis. The work includes studying genetic mutations in JIA patients and how these mutations affect the production of IL-17 and IFN-γ, potentially identifying new targets for therapy. The research combines laboratory experiments with training for the investigator to advance translational skills that could benefit children with JIA. By identifying biologic factors that influence disease pathways, the project aims to inform better diagnostic and treatment decisions for young patients. The plan emphasizes a pathway from basic biology to clinically relevant insights that could guide future trials and care.

Why it matters

Potential benefit: If successful, the work could lead to better diagnostics and targeted treatments for children with JIA.

How similar studies have gone: Previous studies have linked Th1/Th17 cells and IL-17/IFN-γ to JIA, with ongoing efforts to translate these findings into therapies.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Patrick, Anna Elizabeth — Vanderbilt University Medical Center
  • Study coordinator: Patrick, Anna Elizabeth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.